Caseware UK (AP4) 2023.0.135 2023.0.135 2025-01-312025-01-31Steven Jewell Sarah Jewelltruefalse22024-01-10Scientific and technical activitiestrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 15401654 2024-01-09 15401654 2024-01-10 2025-01-31 15401654 2023-02-01 2024-01-09 15401654 2025-01-31 15401654 c:Director2 2024-01-10 2025-01-31 15401654 d:CurrentFinancialInstruments 2025-01-31 15401654 d:CurrentFinancialInstruments d:WithinOneYear 2025-01-31 15401654 d:ShareCapital 2025-01-31 15401654 d:RetainedEarningsAccumulatedLosses 2025-01-31 15401654 c:FRS102 2024-01-10 2025-01-31 15401654 c:AuditExempt-NoAccountantsReport 2024-01-10 2025-01-31 15401654 c:FullAccounts 2024-01-10 2025-01-31 15401654 c:PrivateLimitedCompanyLtd 2024-01-10 2025-01-31 15401654 2 2024-01-10 2025-01-31 15401654 e:PoundSterling 2024-01-10 2025-01-31 iso4217:GBP xbrli:pure

Registered number: 15401654










CAPITAL CHEMICALS LIMITED








UNAUDITED

FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 JANUARY 2025

 
CAPITAL CHEMICAL LIMITED
REGISTERED NUMBER: 15401654

BALANCE SHEET
AS AT 31 JANUARY 2025

2025
Note
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
1,874

Cash at bank and in hand
  
23,252

  
25,126

Creditors: amounts falling due within one year
 5 
(11,267)

Net current assets
  
 
 
13,859

Total assets less current liabilities
  
13,859

  

Net assets
  
13,859


Capital and reserves
  

Called up share capital 
  
100

Profit and loss account
  
13,759

  
13,859


Page 1

 
CAPITAL CHEMICAL LIMITED
REGISTERED NUMBER: 15401654
    
BALANCE SHEET (CONTINUED)
AS AT 31 JANUARY 2025

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
S Jewell
Director

Date: 30 April 2025

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
CAPITAL CHEMICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JANUARY 2025

1.


General information

Capital Chemicals Limited is a private company, limited by shares, registered in England and Wales, registration number 15401654. The registered office address is Terminal 11, St. Mawgan, Newquay, TR8 4UP.
Principles activities
The principal activity of the Company during the year is scientific and technical activities.
The date of incorporation and commencement of trade was 10th January 2024.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the Profit and Loss Account except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Profit and Loss Account within 'finance income or costs'. All other foreign exchange gains and losses are presented in the Profit and Loss Account within 'other operating income'.

Page 3

 
CAPITAL CHEMICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JANUARY 2025

2.Accounting policies (continued)

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

 
2.4

Interest income

Interest income is recognised in the Profit and Loss Account using the effective interest method.

 
2.5

Taxation

Tax is recognised in the Profit and Loss Account except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date in the countries where the Company operates and generates income.


 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at transaction price, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice.. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at transaction price, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 4

 
CAPITAL CHEMICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JANUARY 2025

2.Accounting policies (continued)

 
2.9

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.
Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at transaction price, net of transaction costs, and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.
Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Profit and Loss Account.
For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.
For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the Balance Sheet date.
Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

 
2.10

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees




The average monthly number of employees, including directors, during the period was 2.
 

Page 5

 
CAPITAL CHEMICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JANUARY 2025

4.


Debtors

2025
£


Other debtors
1,874

1,874



5.


Creditors: Amounts falling due within one year

2025
£

Corporation tax
9,017

Accruals and deferred income
2,250

11,267



6.


Related party transactions

In accordance with FRS 102 35.1AC, the Company is exempt from requirements to disclose transactions with other wholly owned members of the group.


7.


Controlling party

The ultimate controlling party is Mr Steven Jewell and Mrs Sarah Jewell.

 
Page 6